Remove Pharma Companies Remove Pharmacy Remove Regulation Remove Vaccine
article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients ā€” and especially the pharma companies that promote them ā€” but a wrong long-term value for healthcare costs.

article thumbnail

Can J&Jā€™s vaccine approval erase bad pharma?

World of DTC Marketing

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? The answer is NO.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

To help solve patient distrust in pharma, industry collaboration is key

pharmaphorum

Pharma companies are now household names, having been thrust into the publicā€™s consciousness after dominating the headlines through the pandemic. These efforts, as Nadhim Zahawi rightly said when he was Vaccines Minister, have led to the life sciences and pharma industry becoming a UK national treasure.

article thumbnail

On Clinical Trials Day, CVS shares lessons learned from one year providing trial services

pharmaphorum

In recent years the retail pharmacy chain has begun to delve more and more deeply into the healthcare sector ā€“ by constantly expanding the basic healthcare services offered at their instore Minute Clinics, and by buying into the health insurance insurance space with their $69 billion purchase of Aetna in 2017.

article thumbnail

European Commission vs Big Pharma, or profit vs access? Ā 

Drug Discovery World

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drugā€™s marketing authorisation to another company before withdrawing it from the market. She also does not believe that the problems with Europeā€™s medicines can be solved with regulation.

article thumbnail

Pricing, Profits and Progress: Pharmaā€™s Post-COVID Priorities

pharmaphorum

The need for firms to make a reasonable profit is paramount in todayā€™s world; healthy pharmaceutical research and manufacturing are the keys to ending disease, curing chronic conditions, and discovering new therapies and vaccines that address the latest medical challenges. Is the Middleman at Fault?

article thumbnail

A history of the pharmaceutical industry

pharmaphorum

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. Merck in Germany was possibly the earliest company to move in this direction. Thalidomide and the development of drug safety regulation and monitoring. pharmaphorum looks at its evolution over the centuries.

Medicine 145